Page last updated: 2024-08-17

gibberellic acid and Angiogenesis, Pathologic

gibberellic acid has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Qing, C; Zeng, X; Zhang, H; Zhang, Y; Zhao, H	1

Other Studies

1 other study(ies) available for gibberellic acid and Angiogenesis, Pathologic

Article	Year
Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative. Investigational new drugs, 2012, Volume: 30, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemotaxis; Dose-Response Relationship, Drug; Gibberellins; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Lethal Dose 50; Lung Neoplasms; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Neovascularization, Physiologic; Thalidomide; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012

Article

Year

Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.

Investigational new drugs, 2012, Volume: 30, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemotaxis; Dose-Response Relationship, Drug; Gibberellins; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Lethal Dose 50; Lung Neoplasms; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Neovascularization, Physiologic; Thalidomide; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012